Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis

Phage therapy against Achromobacter xylosoxidan s lung infection in a patient with cystic fibrosis: a case report

(2018) N. Hoyle et al.   RESEARCH IN MICROBIOLOGY

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review

(2018) Martina Rossitto et al.   Frontiers in Microbiology

Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection

(2017) Rachel Y. Chang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa -infected airways

(2017) Stephanie Trend et al.   Journal of Cystic Fibrosis

Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis

(2017) Robert D Gray et al.   THORAX

Conditionally reprogrammed primary airway epithelial cells maintain morphology, lineage and disease specific functional characteristics

(2017) Kelly M. Martinovich et al.   Scientific Reports

Impaired airway epithelial cell responses from children with asthma to rhinoviral infection

(2016) A. Kicic et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Evolutionary Ecology of Prokaryotic Immune Mechanisms

(2016) Stineke van Houte et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections

(2016) Sharon S. Y. Leung et al.   PHARMACEUTICAL RESEARCH

Evaluation of methods to purify virus-like particles for metagenomic sequencing of intestinal viromes

(2015) Manuel Kleiner et al.   BMC GENOMICS

Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically DiversePseudomonas aeruginosafrom Cystic Fibrosis Patients

(2015) Jaspreet Singh Sahota et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Molecular surveillance for carbapenemase genes in carbapenem resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis

(2015) Anna S. Tai et al.   PATHOLOGY

Quality and Safety Requirements for Sustainable Phage Therapy Products

(2015) Jean-Paul Pirnay et al.   PHARMACEUTICAL RESEARCH

Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood

(2015) Joanna Majewska et al.   Viruses-Basel

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status

(2015) Jean-Marc Rolain et al.   Drug Design Development and Therapy

Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections

(2015) Victor Krylov et al.   VIROLOGICA SINICA

RASTtk: A modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes

(2015) Thomas Brettin et al.   Scientific Reports

PredictingIn VivoEfficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections

(2013) Marine Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Formation of biofilms under phage predation: considerations concerning a biofilm increase

(2013) Zeinab Hosseinidoust et al.   BIOFOULING

Pseudomonas aeruginosa Adaptation to Lungs of Cystic Fibrosis Patients Leads to Lowered Resistance to Phage and Protist Enemies

(2013) Ville-Petri Friman et al.   PLoS One

Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa

(2012) Chloe E James et al.   BMC MICROBIOLOGY

Bacteriophages  MR299-2 and  NH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells

(2012) D. Alemayehu et al.   mBio

Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis

(2011) Naveen Pillarisetti et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Innate Inflammatory Responses of Pediatric Cystic Fibrosis Airway Epithelial Cells

(2011) Erika N. Sutanto et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens

(2011) Leila Kvachadze et al.   Microbial Biotechnology

Host DNA Repair Proteins in Response toPseudomonas aeruginosain Lung Epithelial Cells and in Mice

(2010) Min Wu et al.   INFECTION AND IMMUNITY

Bacteriophage resistance mechanisms

(2010) Simon J. Labrie et al.   NATURE REVIEWS MICROBIOLOGY

The use of antibiotics to improve phage detection and enumeration by the double-layer agar technique

(2009) Sílvio B Santos et al.   BMC MICROBIOLOGY

Comparative analysis of the widespread and conserved PB1-like viruses infectingPseudomonas aeruginosa

(2009) Pieter-Jan Ceyssens et al.   ENVIRONMENTAL MICROBIOLOGY

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

(2009) Maya Merabishvili et al.   PLoS One

Association between MucoidPseudomonasInfection and Bronchiectasis in Children with Cystic Fibrosis

(2009) Philip M. Farrell et al.   RADIOLOGY

Comparison of techniques for obtaining lower airway epithelial cells from children

(2008) P. S. McNamara et al.   EUROPEAN RESPIRATORY JOURNAL

Phage therapy experience at the Eliava Institute

(2008) M. Kutateladze et al.   MEDECINE ET MALADIES INFECTIEUSES